Doxepin analogs and methods of use thereof

Details for Australian Patent Application No. 2004299459 (hide)

Owner Hypnion, Inc.

Inventors Hangauer, David G.; White, James F.; Edgar, Dale M.; Solomon, Michael

Agent Cullen & Co

Pub. Number AU-A-2004299459

PCT Pub. Number WO2005/058880

Priority 10/831,423 23.04.04 US; 60/528,393 10.12.03 US

Filing date 10 December 2004

Wipo publication date 30 June 2005

International Classifications

A61K 31/452 (2006.01) - Piperidinium derivatives

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/058880 Priority application(s): WO2005/058880

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299461-2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists

2004299457-A human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1